UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated clinical models for VTE prediction in hospitalized medical patients

Thrombosis research, 2018-04, Vol.164, p.S62-S69

2018

Volltextzugriff (PDF)

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1372-1381

2018

Volltextzugriff (PDF)

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Thrombosis research, 2020-07, Vol.191, p.S50-S57

2020

Volltextzugriff (PDF)

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Thrombosis research, 2020-03, Vol.187, p.170-179

2020

Volltextzugriff (PDF)

Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study

Thrombosis and haemostasis, 2022-10, Vol.122 (10), p.1662-1672

2022

Volltextzugriff (PDF)

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

Clinical and Applied Thrombosis/Hemostasis, 2022, Vol.28, p.10760296221097969-10760296221097969

2022

Volltextzugriff (PDF)

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.10760296211033906-10760296211033906

2021

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Volltextzugriff (PDF)

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.992-1007

2021

Volltextzugriff (PDF)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Therapeutics and clinical risk management, 2014-01, Vol.10 (default), p.423-436

2014

Volltextzugriff (PDF)

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Thrombosis journal, 2017-03, Vol.15 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-07, Vol.3 (3), p.e309-e315

2019

Volltextzugriff (PDF)

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28

2022

Volltextzugriff (PDF)

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study

Clinical and applied thrombosis/hemostasis, 2020, Vol.26, p.1076029620964590-1076029620964590

2020

Volltextzugriff (PDF)

Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay

Thrombosis journal, 2005-10, Vol.3 (1), p.16-16, Article 16

2005

Volltextzugriff (PDF)

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots

Research and practice in thrombosis and haemostasis, 2018-10, Vol.2 (4), p.696-707

2018

Volltextzugriff (PDF)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Blood cancer journal (New York), 2018-11, Vol.8 (11), p.102-13, Article 102

2018

Volltextzugriff (PDF)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e340-e347

2019

Volltextzugriff (PDF)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

TH open : companion journal to thrombosis and haemostasis, 2019-10, Vol.3 (4), p.e348-e349

2019

Volltextzugriff (PDF)

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Hemato, 2022-03, Vol.3 (1), p.204-218

2022

Volltextzugriff (PDF)

Calpastatin Controls Polymicrobial Sepsis by Limiting Procoagulant Microparticle Release

American journal of respiratory and critical care medicine, 2012-04, Vol.185 (7), p.744-755

2012

Volltextzugriff (PDF)

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Blood, 2021-11, Vol.138 (Supplement 1), p.3213-3213

2021

Volltextzugriff (PDF)

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Blood, 2023-11, Vol.142 (Supplement 1), p.5406-5406

2023

Volltextzugriff (PDF)

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Blood, 2022-11, Vol.140 (Supplement 1), p.11211-11213

2022

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(85)
Buchkapitel
(2)

Sprache

Englisch
(82)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updated clinical models for VTE prediction in hospitalized medical patients

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Endothelial Cell Activation and Thrombin Generation Assessment for the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP Study

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study

Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Calpastatin Controls Polymicrobial Sepsis by Limiting Procoagulant Microparticle Release

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Aktive Filter

Suchergebnisse filtern